Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-29

FDA Approved: ESCITALOPRAM — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application for escitalopram from Macleods Pharmaceuticals Limited, enabling the marketing of their generic escitalopram product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

SUPPL AP for ESCITALOPRAM (ESCITALOPRAM)